“Double-strength 300 mg extract delivering ~240 mg silymarin”
The label discloses a double-strength (2:1) extract standardized to 80% silymarin, computing to ~240 mg silymarin per capsule.
A liver-herb shelf staple, not a clean isolate
A strong-value big bottle for anyone who actively wants the traditional liver-herb stack. NOW pairs a real double-strength silymarin dose with artichoke and dandelion — two classic liver-support herbs — in a 200-count bottle from a large, UL-audited GMP manufacturer. The trade-off is scientific tidiness: with three herbs in the capsule you can't cleanly attribute effects to milk thistle alone.
Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete Milk Thistle (Silymarin) guide →A plain (non-phytosome) 2:1 double-strength silymarin concentrate combined with artichoke and dandelion. Absorption is the standard ceiling, and the blend format means milk thistle isn't the only active — decent form for the money, nothing enhanced.
~240 mg silymarin per capsule from an 80% double-strength concentrate — a real dose in the same range as the value picks, with two caps clearing the trial window.
UL-audited GMP manufacturing and non-GMO status from a large, well-regarded brand. Above brand-only attestations, but there's no independent NSF or USP product seal.
A 200-count bottle for ~$22 is excellent per-capsule value, and the bundled herbs add coverage. Slightly behind the outright cost-per-mg leader, but a lot of bottle for the money.
Vegetarian/vegan capsules and generally well tolerated, but the three-herb blend is the drawback — you can't attribute effects, or a reaction, to milk thistle cleanly.
“Double-strength 300 mg extract delivering ~240 mg silymarin”
The label discloses a double-strength (2:1) extract standardized to 80% silymarin, computing to ~240 mg silymarin per capsule.
“Includes artichoke and dandelion for liver support”
The label lists artichoke and dandelion as additional ingredients — two herbs traditionally used for liver and digestive support.
“UL-audited GMP manufacturing”
NOW Foods manufactures in a UL-audited GMP facility, a documented quality process above brand-only attestation.
“Supports liver detoxification and function”
The blend is traditionally used for liver support, but controlled evidence for silymarin is mixed (Rambaldi 2007), and the artichoke/dandelion additions are not backed by strong outcome trials here.
This isn't trying to be a clean milk thistle isolate — it's a liver-herb blend. Artichoke and dandelion ride along with a real silymarin dose, which is a plus if you want broad 'liver support' and a minus if you want attribution.
200 capsules at ~$22 is roughly $0.11 each — outstanding per-capsule value. It trails Nutricost only on pure cost-per-mg-of-silymarin because part of what you pay for is the extra herbs.
NOW's UL-audited GMP process and scale put its QC above brand-only attestation, even without an independent product seal — a reassuring middle ground on the 20%-weighted testing axis.
With three actives, you can't isolate milk thistle's contribution — and the underlying silymarin evidence is already mixed. Fine as a shelf staple; not the pick for a controlled milk thistle trial of your own.
A strong-value big bottle if you actively want the traditional liver-herb stack — artichoke and dandelion ride along with a real silymarin dose. The trade-off is scientific tidiness: with three herbs in the capsule you lose clean attribution, which is why it sits behind the single-ingredient value pick. Great for a 'liver support' shelf staple, less ideal if you want to isolate what milk thistle is doing.
The same silymarin dose without the extra herbs, at the best cost-per-mg here.
See it on the list →A cleaner single-ingredient vegan option — cheaper per cap but a lower dose.
See it on the list →A guaranteed-potency, single-herb one-a-day if attribution matters to you.
See it on the list →No significant mortality benefit of milk thistle was found in liver disease versus placebo.
Narrative review reports supportive liver effects for silymarin at a lower evidence tier than RCTs.